A Trial of FANG™ Vaccine for Participants With Ovarian Cancer
NCT01309230
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Interventions
BIOLOGICAL:
Vigil™
Sponsor
Gradalis, Inc.